Skip to content

Author

H. Sakuraba

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

The prognostic impact of CDH1 and MEG3 methylation status in multiple myeloma.

It is found that methylation was associated with poor prognosis in multiple myeloma and a trend toward reduced overall survival in the CDH1 methylated and MEG3 unmethylated patient groups suggested that CDH1 promoter hypermethylation and MEG3 promoter unmethylation status may predict poor MM prognoses.

Satoru Yamashita, T. Tachita, Kosuke Kamata et al. · 0 citations
Open access Sep 2026

Delayed and multisystem immune-related adverse events in MSI-high colon cancer treated with nivolumab plus ipilimumab.

Immune checkpoint inhibitors (ICIs) can cause immune-related adverse events (irAEs) involving multiple organs. However, delayed-onset, multisystem irAEs after treatment discontinuation are uncommon. Here, we present a rare case of a man in his 50s with microsatellite instability-high colon cancer who developed multisys...

Takato Maeda, Masaki Munakata, H. Numao et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.